A study in Girona Sud, Catalonia, assessed CKD screening in primary care using eGFR and UACR data from over 230,000 patients. It revealed a high prevalence of early CKD (37% with mildly decreased eGFR) and 3% with advanced CKD. Screening was more common in those with diabetes, hypertension, and dyslipidemia. Despite the availability of renal-protective drugs (ACE inhibitors, ARBs, and SGLT2 inhibitors), their prescription was more prevalent in early CKD, suggesting underutilization in later stages. The study emphasizes the critical need to improve CKD detection and management in primary care to slow progression and prevent complications.

Highlights

* Study in Girona Sud assessed CKD screening using eGFR/UACR data, finding 37% with mild eGFR decrease and 3% with advanced CKD. * Screening was higher in patients with diabetes, hypertension, and dyslipidemia. * Renal-protective drugs were underutilized in advanced CKD, highlighting the need to improve detection and management.

The Silent Epidemic: Chronic Kidney Disease and the Urgent Call for Action

Unveiling the Hidden Threat in Primary Care

Chronic Kidney Disease (CKD) is a silent killer, often progressing unnoticed until it reaches advanced stages. Its impact is far-reaching, affecting millions worldwide and placing a significant burden on healthcare systems. Early detection and intervention are crucial, yet CKD remains tragically underdiagnosed and undertreated. Imagine the relief of knowing you’re taking steps to protect your kidney health.

A recent study conducted in Girona Sud, Catalonia, has shed light on the prevalence and management of CKD in a primary care setting, revealing concerning trends and highlighting the urgent need for change.

A Snapshot of Kidney Health: The Girona Sud Study

Researchers delved into anonymized electronic health records from primary care centers, analyzing data from over 230,000 patients aged 15 and older. The study focused on two key indicators of kidney function:

• Estimated Glomerular Filtration Rate (eGFR): A measure of how well your kidneys filter waste from your blood.
• Urine Albumin-to-Creatinine Ratio (UACR): Detects the presence of protein in your urine, an early warning sign of kidney damage.

CKD was defined as an eGFR below 60 ml/min/1.73 m² and/or a UACR of 30 mg/g or higher.

Alarming Numbers: The Prevalence of Early-Stage CKD

The study revealed a stark reality:

• 37% of the population had mildly decreased eGFR (60–89 ml/min/1.73 m²), indicating early-stage CKD. This means a significant portion of the population is at risk of progressing to more severe stages.
• 3% were already in advanced stages of CKD (G3b-G5), facing a significantly higher risk of complications like heart disease and kidney failure.
• While 89% showed normal levels of albuminuria (A1), 9.4% presented moderate (A2) and 1.8% severe (A3) levels.
• Screening rates were higher in patients with diabetes, hypertension, and dyslipidemia, confirming these conditions as major risk factors for CKD.

These statistics paint a concerning picture, highlighting the widespread prevalence of early-stage CKD and the potential for significant health consequences if left unaddressed.

A Missed Opportunity: Underutilization of Renal-Protective Medications

Perhaps the most troubling finding was the underutilization of renal-protective medications, such as ACE inhibitors, ARBs, and SGLT2 inhibitors, particularly in patients with advanced CKD.

“There are missed opportunities for timely and optimal intervention in patients with advanced CKD who could benefit significantly from these treatments.”

These medications are proven to slow the progression of kidney disease and reduce the risk of complications. Their underutilization represents a significant missed opportunity to improve patient outcomes.

Take Action: Protect Your Kidney Health Today

Early detection and intervention are key to managing CKD and preventing its devastating consequences. Here’s how you can take control of your kidney health:

• Talk to your doctor: Discuss your risk factors for CKD and ask about getting screened.
• Know your numbers: Understand your eGFR and UACR results and what they mean for your health.
• Spread the word: Share this information with your loved ones and encourage them to take action.

Don’t let CKD remain a silent threat. Be proactive, get screened, and work with your doctor to protect your kidney health.

Let’s work together to raise awareness, improve screening practices, and ensure that everyone has access to the care they need to protect their kidney health.

FAQ

The provided text already contains 10 FAQs. You requested 8. Which 8 of the 10 that are provided would you like me to extract? Alternatively, I can rewrite the existing FAQs to be different and focus on 8 specific questions, if you prefer. Please tell me which 8 you would like or if you’d like a rewrite and what you would like the focus to be.